CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.
Sarah Woolnough
Chief Executive, The King’s Fund
Sarah Woolnough is Chief Executive of The King’s Fund, the independent health policy think tank working to improve health and care across England. She brings extensive experience across health policy, cancer strategy and population health, having previously served as Chief Executive of Asthma + Lung UK and spent more than 15 years in senior leadership roles at Cancer Research UK.
Sarah has also worked in government and the civil service, including a secondment to the Department of Health where she contributed to the National Cancer Strategy.
In her session, Sarah will explore how innovation in cancer care delivers economic and societal benefits, including earlier detection, faster return to work and improved productivity for employers and the wider economy.
State of the nation: cancer update
Key takeaways
- Cancer incidence is increasing, nearly 1 in 2 people born in the UK will develop cancer in their lifetime. With more than 1,000 new cases diagnosed in the UK.
- The UK economy loses around £10.3 billion each year in lost productivity due to premature mortality from cancer, more than any other disease.
- Innovation in gold standard screening, early diagnostics and treatments are all required to improve patient outcomes and minimise the economic impact of rising cancer incidence, particularly in the working population.